Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$858M |
| 2 |
Costco
COST
|
+$557M |
| 3 |
UnitedHealth
UNH
|
+$551M |
| 4 |
Atlassian
TEAM
|
+$489M |
| 5 |
Northrop Grumman
NOC
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$579M |
| 2 |
TSMC
TSM
|
+$433M |
| 3 |
Airbnb
ABNB
|
+$426M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$341M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.22% |
| 2 | Consumer Discretionary | 23.3% |
| 3 | Healthcare | 16.47% |
| 4 | Financials | 9.42% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Celldex Therapeutics
CLDX
$3.07B
| $35.8M | 0.04% |
+1,274,021
| New | +$39.1M |
|
227
Universal Display
OLED
$3.96B
| $35.5M | 0.04% |
375,903
+78,314
| +26% | +$8.67M |
|
228
Halliburton
HAL
$27B
| $35.4M | 0.04% |
1,436,517
+550
| +0% | +$15.7K |
|
|
UMH
229
UMH Properties
UMH
$1.3B
| $35.4M | 0.04% |
2,189,416
+681,272
| +45% | +$12.8M |
|
230
Valero Energy
VLO
$88.9B
| $34.8M | 0.03% |
325,393
-102,098
| -24% | -$11.2M |
|
231
FirstEnergy
FE
$27.9B
| $34.6M | 0.03% |
935,332
-2,214
| -0.2% | -$87.5K |
|
232
KE Holdings
BEKE
$18.9B
| $34.6M | 0.03% |
1,973,279
-595,456
| -23% | -$9.64M |
|
233
CBRE Group
CBRE
$43.7B
| $34.5M | 0.03% |
510,448
-28,133
| -5% | -$2.23M |
|
234
Western Midstream Partners
WES
$19.3B
| $34.2M | 0.03% |
1,359,773
| – | – |
|
235
Ametek
AME
$58.2B
| $34.1M | 0.03% |
300,719
-30,469
| -9% | -$3.65M |
|
236
Prologis
PLD
$130B
| $33.9M | 0.03% |
334,027
+26,155
| +8% | +$3.24M |
|
237
Clearway Energy Class C
CWEN
$4.94B
| $33.8M | 0.03% |
1,061,389
+626
| +0.1% | +$23K |
|
238
IQVIA
IQV
$37.6B
| $33.6M | 0.03% |
185,434
-55,592
| -23% | -$12.2M |
|
239
Texas Roadhouse
TXRH
$13.7B
| $33.5M | 0.03% |
384,338
+26,644
| +7% | +$2.32M |
|
240
Devon Energy
DVN
$50.8B
| $32.7M | 0.03% |
543,026
-28,813
| -5% | -$1.79M |
|
241
Houlihan Lokey
HLI
$8.96B
| $32.4M | 0.03% |
429,641
-1,678
| -0.4% | -$136K |
|
242
Pinduoduo
PDD
$130B
| $32.3M | 0.03% |
516,038
+53,743
| +12% | +$3.12M |
|
243
AES
AES
$10.5B
| $32.3M | 0.03% |
1,427,584
-396,193
| -22% | -$9.39M |
|
244
Alliant Energy
LNT
$18.3B
| $32.2M | 0.03% |
607,561
-988,479
| -62% | -$59.6M |
|
245
Public Service Enterprise Group
PEG
$38B
| $31.8M | 0.03% |
565,229
-879,878
| -61% | -$56.7M |
|
|
PPL
246
PPL Corp
PPL
$26.5B
| $31.6M | 0.03% |
+1,248,150
| New | +$35.7M |
|
247
Prestige Consumer Healthcare
PBH
$2.46B
| $31.6M | 0.03% |
633,188
+183,121
| +41% | +$10.1M |
|
248
Toll Brothers
TOL
$14.3B
| $31.1M | 0.03% |
739,683
+180,824
| +32% | +$8.38M |
|
249
Vistra
VST
$48.3B
| $31M | 0.03% |
+1,474,536
| New | +$35.7M |
|
|
SILK
250
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $30.9M | 0.03% |
686,044
+235,762
| +52% | +$10.1M |
|
Similar funds
Jennison Associates's Q3 2022 Portfolio in Review
As of Q3 2022, Jennison Associates held 689 positions worth $101B, up 0.37% from $100B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates's Q3 2022 filing shows 75 new, 294 increased, 218 reduced and 90 closed positions. Its largest new stake was T-Mobile US: 1,657,443 shares worth $222M. The largest sale was Nike, an estimated $579M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2022 buy was T-Mobile US: 1,657,443 shares worth $222M.
- Jennison Associates added most to Vertex Pharmaceuticals in Q3 2022, an estimated $858M increase.
- Jennison Associates's biggest Q3 2022 reduction was Nike, cutting an estimated $579M.
- Jennison Associates fully exited Snap in Q3 2022, selling an estimated $197M.
- Jennison Associates's ten largest holdings make up 40% of its $101B portfolio in Q3 2022.
- Jennison Associates opened 75 new positions and closed 90 in Q3 2022.
- Jennison Associates's portfolio value rose 0.37% quarter-over-quarter to $101B.
Based on Jennison Associates's 13F filing for Q3 2022, filed 1 Nov 2022.